CymitQuimica logo
Angiogenesis

Angiogenesis

Angiogenesis inhibitors are compounds that interfere with the formation of new blood vessels, a process critical in cancer growth and metastasis. By inhibiting angiogenesis, these compounds can restrict the blood supply to tumors, slowing or halting their growth. Angiogenesis inhibitors are essential in cancer research and therapeutic development, providing insights into the mechanisms of tumor progression and offering potential treatments for cancer and other angiogenesis-related diseases. At CymitQuimica, we offer a wide range of high-quality angiogenesis inhibitors to support your research in oncology and vascular biology.

Subcategories of "Angiogenesis"

Show 6 more subcategories

Found 2379 products of "Angiogenesis"

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • VnP-16


    VnP-16 enhances bone formation by stimulating the differentiation and activity of osteoblasts via direct β1 integrin engagement, which subsequently activates
    Formula:C82H112N20O17
    Purity:98%
    Color and Shape:Solid
    Molecular weight:1649.89

    Ref: TM-T80529

    5mg
    To inquire
    50mg
    To inquire
  • PF15 TFA


    PF15 TFA, a PROTAC targeting FLT3 kinase and CRBN, exhibits selective degradation of FLT3-ITD with a DC50 of 76.7 nM.
    Formula:C46H50F3N13O8
    Purity:98%
    Color and Shape:Solid
    Molecular weight:969.97

    Ref: TM-T77932

    5mg
    To inquire
    50mg
    To inquire
  • Coprelotamab

    CAS:

    Coprelotamab (GB-221) is an IgG-κ monoclonal antibody that targets EGFR2, frequently produced in CHO DG44 (Chinese Hamster Ovary) cells [1].

    Purity:98%
    Color and Shape:Liquid

    Ref: TM-T80596

    1mg
    To inquire
    5mg
    To inquire
  • Syk Inhibitor II hydrochloride

    CAS:
    Syk signaling is key in lupus. Syk inhibitors reduce inflammation and sepsis severity in FcgRIIb-/- mice, lowering cytokines and organ damage.
    Formula:C14H16ClF3N6O
    Purity:99.05%
    Color and Shape:Solid
    Molecular weight:376.77

    Ref: TM-T9543

    1mg
    38.00€
    5mg
    73.00€
    10mg
    124.00€
    25mg
    205.00€
    50mg
    320.00€
    100mg
    513.00€
    1mL*10mM (DMSO)
    81.00€
  • FLT3-IN-22


    FLT3-IN-22 (compound 22f) is a potent inhibitor of FLT3, demonstrating IC50 values of 0.941 nM for FLT3 and 0.199 nM for the FLT3/D835Y mutant.
    Formula:C24H22N6O2
    Color and Shape:Solid
    Molecular weight:426.47

    Ref: TM-T79420

    5mg
    To inquire
    50mg
    To inquire
  • MS9427 TFA


    MS9427 TFA: PROTAC EGFR degrader, Kd 7.1 nM (WT), 4.3 nM (L858R), targets mutant EGFR, inhibits NSCLC cell growth, for cancer research.
    Formula:C50H59ClF4N8O14
    Color and Shape:Solid
    Molecular weight:1107.5

    Ref: TM-T74634

    5mg
    To inquire
    50mg
    To inquire
  • VEGFR-2-IN-64


    VEGFR-2-IN-64 (Compound 28) is an inhibitor of VEGFR2 with an IC50 of 27.8 nM. It suppresses the proliferation of cancer cells A549, T-47D, and Caco-2, exhibits anti-migration and anti-colony formation activities in T-47D cells, and induces apoptosis in T-47D cells.
    Formula:C72H123N9O6
    Color and Shape:Solid
    Molecular weight:1210.8

    Ref: TM-T204271

    10mg
    To inquire
    50mg
    To inquire
  • CS-VIP 8 TFA


    CS-VIP 8 TFA is a selective allosteric inhibitor of the WDR5 protein (Ki= 0.008 μM). It induces a conformational change in the MLL1 complex, leading to the dissociation of MLL1 from the complex, thereby inhibiting the MLL1 histone methyltransferase activity and modulating HOX gene expression. CS-VIP 8 TFA shows potential for research in hematological disorders such as leukemia.
    Formula:C45H53F7N12O9
    Color and Shape:Solid
    Molecular weight:1038.39467

    Ref: TM-T207391

    10mg
    To inquire
    50mg
    To inquire
  • PROTAC FAK degrader 1

    CAS:
    PROTAC FAK degrader 1 is a selective and potent degrader of focal adhesion kinase (Fak) (IC50 of 6.5 nM).
    Formula:C47H56F3N9O8S2
    Purity:98%
    Color and Shape:Solid
    Molecular weight:996.13

    Ref: TM-T13840

    1mg
    410.00€
    5mg
    732.00€
    10mg
    1,116.00€
    50mg
    To inquire
    100mg
    To inquire
  • PLM-101


    PLM-101 is an anticancer compound orally active against acute myeloid leukemia by targeting FLT3 and RET.
    Formula:C22H22FN5O2
    Color and Shape:Solid
    Molecular weight:407.44

    Ref: TM-T78871

    5mg
    To inquire
    50mg
    To inquire
  • VGB3


    VGB3 is a peptide antagonist of vascular endothelial growth factor receptor 1 (VEGFR1) and VEGFR2, exhibiting anti-angiogenic and anti-tumor properties. It binds to VEGFR1 and VEGFR2, thereby inhibiting VEGF-driven endothelial cell proliferation, migration, and tube formation, as well as suppressing tumor growth and metastasis in a mouse 4T1 breast cancer model.
    Formula:C67H101N19O21S2
    Color and Shape:Solid
    Molecular weight:1572.76

    Ref: TM-TP2984

    10mg
    To inquire
    50mg
    To inquire
  • BCPyr

    CAS:
    BCPyr is a new candidate BTK degrader ( DC 50 = 800 nM).
    Formula:C58H65F2N11O8
    Color and Shape:Solid
    Molecular weight:1082.224

    Ref: TM-T40300

    25mg
    To inquire
  • VSLRGDTRG acetate


    VSLRGDTRG acetate is a synthetic peptide of the RGD motif from cadherin17 (CDH17), capable of binding to α2β1 integrin and activating its signaling pathways. It facilitates the high-affinity conformational change of β1 integrin via the RGD motif, enhancing cell adhesion and phosphorylation of FAK and ERK1/2, thereby promoting tumor proliferation and metastasis. VSLRGDTRG acetate is applicable in research on cancers expressing CDH17, such as colon and pancreatic cancers.
    Color and Shape:Odour Solid

    Ref: TM-TP3245

    10mg
    To inquire
    50mg
    To inquire
  • BTK degrader-1

    CAS:
    BTK degrader-1 (compound 1), a bifunctional degrader of Bruton's tyrosine kinase (BTK), demonstrates the capability to be conjugated with CD79b and exhibits anti-tumor effects [1].
    Formula:C52H54F2N8O6
    Color and Shape:Solid
    Molecular weight:925.03

    Ref: TM-T87718

    10mg
    To inquire
    50mg
    To inquire
  • SA-PA


    SA-PA, a self-assembled intracellular PROTAC leveraging azide-alkyne click chemistry, selectively degrades VEGFR-2, PDGFR-β, and EphB4 proteins within U87 cells
    Formula:C40H32ClF3N10O8
    Purity:98%
    Color and Shape:Solid
    Molecular weight:873.19

    Ref: TM-T79530

    5mg
    To inquire
    50mg
    To inquire
  • BIIB091

    CAS:
    BIIB091 is a highly selective, reversible BTK inhibitor for treating autoimmune diseases.
    Formula:C28H34N10O2
    Color and Shape:Solid
    Molecular weight:542.648

    Ref: TM-T39761

    5mg
    807.00€
    10mg
    1,305.00€
  • TYK2 activator-1


    TYK2activator-1 (16b) is a TYK2 activator with an EC50 value of 1.78 μM. It inhibits JAK2 and JAK3 with IC50 values of 6.8 μM and 6.3 μM, respectively.
    Formula:C23H21FN4O2
    Color and Shape:Solid
    Molecular weight:404.16485

    Ref: TM-T207637

    10mg
    To inquire
    50mg
    To inquire
  • WDR5 ligand 2

    CAS:
    WDR5ligand 2 is a ligand for WDR5 and can be utilized in the synthesis of PROTAC WDR5degrader 1.
    Formula:C29H31F3N4O4
    Color and Shape:Solid
    Molecular weight:556.576

    Ref: TM-T205322

    10mg
    To inquire
    50mg
    To inquire
  • EGFR/CDK2-IN-4


    EGFR/CDK2-IN-4 (compound 4c) is a dual inhibitor targeting EGFR and CDK-2, demonstrating IC50 values of 89.6 nM for EGFR and 165.4 nM for CDK-2.
    Formula:C24H16N6OS2
    Purity:98%
    Color and Shape:Solid
    Molecular weight:468.55

    Ref: TM-T79729

    5mg
    To inquire
    50mg
    To inquire
  • EGFR-IN-148


    EGFR-IN-148 (compound 8c) is a potent EGFR inhibitor with an IC50 of 0.161 μM. It induces G1/S phase arrest and significantly enhances apoptosis in HepG2 cells.
    Formula:C17H16N4O4S
    Color and Shape:Solid
    Molecular weight:372.398

    Ref: TM-T204893

    10mg
    To inquire
    50mg
    To inquire